A patient comes in with a brown, symmetric patch across the cheekbones and forehead that has been getting darker for two summers. She has tried three over-the-counter brightening serums, a hydroquinone cream prescribed by a primary care physician, and a single laser session at a spa that made the pigment worse for six weeks. She wants to know what actually works. The honest answer is that melasma is one of the most frustrating conditions in aesthetic medicine — and most of the products and procedures marketed for it will either disappoint or actively harm a patient with the wrong skin type.
I want to walk through what I actually recommend, what I refuse to do, and why melasma requires a fundamentally different mindset than other forms of hyperpigmentation.
Why melasma is different from other pigmentation problems
Most hyperpigmentation comes from a single insult — a sunburn, an acne lesion, a cut. Treat the inflammation, fade the pigment, move on. Melasma does not behave that way. It is a chronic, hormonally-modulated, photo-aggravated condition involving overactive melanocytes that have become hypersensitive to UV, visible light (yes, visible light — your phone screen and indoor LEDs count), heat, and estrogen exposure.
That last point matters. When I evaluate a patient with melasma, I am usually looking at someone in her thirties or forties whose pigment showed up during pregnancy, after starting an oral contraceptive, or in the early window of perimenopausal hormonal shift. The melanocytes themselves have not been damaged — they have been activated. They are doing what they have been told to do by an upstream signal. Until you address that signal and protect the skin from the triggers that keep firing it, no peel or laser will produce a durable result.
This is why I see patients who have spent thousands of dollars on treatment that worked for six weeks before the pigment came back, often darker than baseline. The underlying mechanism was never addressed.
The mechanism — what is actually happening in the skin
Melasma involves three layers of dysfunction operating together:
Melanocyte activation. The pigment-producing cells in the basal layer of the epidermis are hyperactive. Estrogen receptors on those cells respond to circulating hormones — which is why pregnancy and oral contraceptives are common triggers. UV and visible light further upregulate melanin production through pathways involving alpha-MSH and tyrosinase.
Melanin deposition at multiple depths. Some melasma is epidermal (pigment in the surface layers), some is dermal (pigment that has dropped into deeper tissue), and most is mixed. Dermal pigment is significantly harder to treat — it is not reachable by topical agents, and aggressive lasers often make it worse by triggering more inflammation and more pigment.
Vascular and inflammatory components. Newer research has identified increased vascularity and chronic low-grade inflammation in melasma-affected skin. This is part of why heat-based treatments — including some IPL and laser settings — can flare the condition. The skin is already in a low-grade inflammatory state. Adding controlled thermal injury sometimes pours gasoline on it.
A treatment plan that ignores any of these layers tends to underperform or backfire.
What actually works — in order of foundation to add-on
I want to be direct about the hierarchy here, because patients regularly want to skip the foundation and jump straight to a procedure. That is the path to making melasma worse.
Sun protection — the foundation that cannot be skipped. This is the most important intervention, full stop. Tinted mineral sunscreen with iron oxides (the iron oxides matter because they block visible light, which standard sunscreens do not), SPF 30 or higher, reapplied every two hours of outdoor exposure. A wide-brimmed hat. The car window matters — UVA passes through automotive glass and is responsible for the asymmetric pigment I see on the left cheek of patients who commute. Patients who do not commit to this part will not hold any result from any procedure.
Topical pigment-modulating agents. Hydroquinone in 4% concentrations remains the workhorse for active melasma, used in cycles (typically eight to twelve weeks on, then a holiday with non-hydroquinone alternatives like cysteamine, tranexamic acid, or azelaic acid). Tretinoin alongside accelerates turnover and improves penetration. The protocol matters — chronic uninterrupted hydroquinone use can cause exogenous ochronosis, a paradoxical darkening, so the cycling is not optional.
Oral tranexamic acid. This is the single most underused tool in melasma treatment. Tranexamic acid taken orally at 250-500 mg twice daily reduces melanocyte activation and has the best evidence base of any systemic agent for stubborn melasma. It requires screening — personal or family history of clotting disorders is a contraindication — and it is not a one-month treatment. Most patients see meaningful change at three to six months. It is the closest thing to a disease-modifying intervention we have.
Targeted in-office treatment. This is where VI Peel earns its place. The VI Peel formulation includes TCA, retinoic acid, salicylic acid, phenol, and vitamin C in concentrations specifically designed to address pigmentation without the heat-driven flare risk of laser. For most melasma patients I evaluate, a series of three peels spaced four weeks apart, layered on top of consistent sun protection and topical management, produces results that hold. The AquaFirme facial protocol has a place for maintenance once the pigment is suppressed.
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
Cautious use of energy-based treatments. Microneedling at conservative settings, sometimes paired with topical tranexamic acid, can help the right patient. I am much more cautious with fractional CO2 laser in melasma — it works for some patients and worsens others. The candidacy decision matters more than the device.
What I refuse to do — and why
This is where I want to be especially direct. Several treatments are aggressively marketed for melasma that I will not perform on most patients with this condition:
IPL on Fitzpatrick IV-VI skin types with active melasma. The risk of post-inflammatory hyperpigmentation is too high. I have inherited too many patients whose pigment doubled after IPL.
Aggressive single-pass CO2 resurfacing on melasma-prone skin. The thermal load triggers rebound pigmentation in a meaningful percentage of patients. There are gentler protocols when ablative work is appropriate.
Pico or Q-switched lasers on patients who have not first stabilized the underlying pigment. Without sun protection, topical management, and often oral tranexamic acid in place, these treatments produce a temporary improvement followed by a more aggressive recurrence.
Combination treatments stacked too quickly. A new patient who arrives wanting a peel, microneedling, and a vampire facial in the same month is asking for an inflammatory cascade. The body needs space between interventions, particularly in melasma-prone tissue.
The vampire facial and microneedling both have legitimate roles in melasma management. The roles are conservative, sequential, and built on a foundation of sun protection and topical pigment control.
How I evaluate a melasma patient
When I see a new patient for pigmentation, I am working through a specific assessment:
- Pattern and distribution. Centrofacial, malar, mandibular — the pattern tells me something about which triggers are dominant.
- Wood's lamp examination. Helps distinguish epidermal from dermal pigment, which changes the prognosis and the protocol.
- Fitzpatrick skin type. Drives which energy-based interventions are even on the table.
- Hormonal context. Pregnancy history, current oral contraceptive use, perimenopausal status, any history of HRT. For some patients, a shift in oral contraceptive or a hormone panel revealing significant estrogen excess opens up an upstream intervention that the dermatology-only approach misses.
- Triggers in the patient's actual life. Daily commute? Hot yoga? Indoor cooking over a gas stove that radiates significant infrared heat to the face? These matter.
- Prior treatment history in detail. What has been tried, at what doses, for how long, and with what response. The patients who arrive having failed three providers usually failed for an identifiable reason that the next plan needs to account for.
- Realistic expectation conversation. Melasma is managed, not cured. Patients who understand this from the beginning do well. Patients who expect a single-procedure permanent fix are going to be disappointed by anything I or anyone else offers.
The realistic timeline
I want patients to hear this number from me before they start: most melasma protocols show meaningful improvement at three months, substantial improvement at six months, and durable maintenance at twelve months and beyond. Anyone promising a six-week complete clearance is either not treating melasma or is going to flare you.
The protocol I most commonly use looks something like:
- Weeks 1-4: establish sun protection routine, initiate topical pigment-modulating regimen, screen for and start oral tranexamic acid if appropriate
- Weeks 4-12: first VI Peel, then a second peel four weeks later, then a third peel four weeks after that
- Months 3-6: assess response, adjust topical protocol, decide on maintenance peels or add conservative microneedling
- Months 6-12: transition to long-term maintenance — continued sun protection, lower-frequency topicals, periodic peels or facials, ongoing tranexamic acid in some patients
The patients who follow this and protect themselves from triggers see their melasma fade and stay faded. The patients who skip the sun protection or stop the topicals when the pigment lightens are the ones who relapse.
The clinical next step
If you have melasma and have not had a structured workup that includes Wood's lamp examination, a hormonal context review, and a candidacy assessment for oral tranexamic acid, that is the conversation worth booking. Bring photographs of the pigment at its worst (most patients have these on their phones), a list of every product and prescription you have tried, and any hormonal history relevant to the timeline of when the pigment appeared.
Book online and select a cosmetic consultation. We will build a real plan from the assessment, and we will start with the foundation before we add any procedures.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.